Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Colonic Neoplasms 2Vitamin D Deficiency 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Cyclophosphamide 6Dexamethasone 5fludarabine 4Bortezomib 468Ga-pentixafor 4Melphalan 3Lenalidomide 3Granulocyte Colony-Stimulating Factor 3Positron Emission Tomography Computed Tomography 2Fluorodeoxyglucose F18 2Filgrastim 2tocilizumab 1ruxolitinib 1pomalidomide 1methyl prednisolonate 1ioversol 1iberdomide 1fludarabine phosphate 1eltrombopag 1elotuzumab 1daratumumab 1carfilzomib 1blinatumomab 1Thalidomide 1Tacrolimus 1Simvastatin 1Prochlorperazine 1Pemetrexed 1Ondansetron 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Multiple Myeloma × Cholecalciferol × Clear all
NCT05846880 2025-04-08

VitD3 Supplementation in Patients With Multiple Myeloma

Augusta University

Phase EARLY_PHASE1 Recruiting
100 enrolled
Plasma cell

Multiple Myeloma, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡